Results 141 to 150 of about 57,540 (217)

Drug Resistance of Imported <i>P. falciparum</i> and <i>P. vivax</i> Isolates - China, 2021-2023. [PDF]

China CDC Wkly
Yan H, Deng Y, Wang S, Yin J, Xia Z, Cao J.   +5 more
europepmc   +1 more source

Household costs associated with zoonotic Plasmodium knowlesi, P. falciparum, P. vivax and P. malariae infections in Sabah, Malaysia. [PDF]

PLoS Negl Trop Dis
Abraham P, McMullin C, William T, Rajahram GS, Jelip J, Teo R, Drakeley C, Manah AM, Anstey NM, Grigg MJ, Devine A.   +10 more
europepmc   +1 more source

An Optimized Dihydrodibenzothiazepine Lead Compound (SBI-0797750) as a Potent and Selective Inhibitor of Plasmodium falciparum and P. vivax Glucose 6-Phosphate Dehydrogenase 6-Phosphogluconolactonase. [PDF]

Antimicrob Agents Chemother, 2022
Berneburg I, Peddibhotla S, Heimsch KC, Haeussler K, Maloney P, Gosalia P, Preuss J, Rahbari M, Skorokhod O, Valente E, Ulliers D, Simula LF, Buchholz K, Hedrick MP, Hershberger P, Chung TDY, Jackson MR, Schwarzer E, Rahlfs S, Bode L, Becker K, Pinkerton AB.   +21 more
europepmc   +1 more source

TLR9 gene polymorphism -1237T/C (rs5743836) is associated with low IgG antibody response against PvCSP variants in symptomatic P. vivax infections in Venezuela. [PDF]

PLoS Negl Trop Dis
Carrión-Nessi FS, Salazar-Alcalá E, Forero-Peña DA, Curiel KA, Lopez-Perez M, Fernández-Mestre M.   +5 more
europepmc   +1 more source

Humoral and cellular immune response to Plasmodium vivax VIR recombinant and synthetic antigens in individuals naturally exposed to P. vivax in the Republic of Korea. [PDF]

Malar J, 2021
Lee S, Choi YK, Goo YK.
europepmc   +1 more source

Evaluation of combination vaccines targeting transmission of Plasmodium falciparum and P. vivax. [PDF]

Vaccine
Cao Y, Hayashi CTH, Araujo MDS, Tripathi AK, Andrade AO, Medeiros JF, Vinetz J, Kumar N.   +7 more
europepmc   +1 more source

Treatment, Prophylaxis and Resistance in P. vivax Malaria [PDF]

International Journal of Infectious Diseases, 2010
openaire   +1 more source

Optimization of loop mediated isothermal amplification assay (LAMP) for detection of chloroquine resistance in P. vivax malaria. [PDF]

Sci Rep
Kaur D, Kaur U, Bhusal CK, Tak V, Sehgal R.   +4 more
europepmc   +1 more source

Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia. [PDF]

Int J Parasitol Drugs Drug Resist, 2021
Marfurt J, Wirjanata G, Prayoga P, Chalfein F, Leonardo L, Sebayang BF, Apriyanti D, Sihombing MAEM, Trianty L, Suwanarusk R, Brockman A, Piera KA, Luo I, Rumaseb A, MacHunter B, Auburn S, Anstey NM, Kenangalem E, Noviyanti R, Russell B, Poespoprodjo JR, Price RN.   +21 more
europepmc   +1 more source

Loop-mediated isothermal amplification (LAMP) assays targeting 18S ribosomal RNA genes for identifying P. vivax and P. ovale species and mitochondrial DNA for detecting the genus Plasmodium. [PDF]

Parasit Vectors, 2021
Chen X, Zhang J, Pan M, Qin Y, Zhao H, Qin P, Yang Q, Li X, Zeng W, Xiang Z, Duan M, Li X, Wang X, Mazier D, Zhang Y, Zhao W, Rosenthal BM, Huang Y, Yang Z.   +18 more
europepmc   +1 more source